{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2019-0002","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2019-0002","name":[{"text":"Zoster: Dose #2 (Shingrix) administered at 4 weeks - 4 days after dose #1\nEvaluation_Test_Type: All Valid: Forecast Test\nGeneral_Description: This test case describes that when a patient is administered the second dose of Shingrix vaccine at 4 weeks - 4 day, that the dose is considered to be valid."}],"gender":"male","birthDate":"1970-06-01"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2019-0002-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2019-0002"},"occurrenceDateTime":"2020-06-01T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2019-0002-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2019-0002"},"occurrenceDateTime":"2020-06-25T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}}]}